147 related articles for article (PubMed ID: 19254268)
1. Viral immune monitoring for post-transplant lymphoproliferative disorder.
Dharnidharka V; Gupta S
Pediatr Transplant; 2009 Aug; 13(5):521-3. PubMed ID: 19254268
[No Abstract] [Full Text] [Related]
2. Localized intraocular posttransplant lymphoproliferative disorder after pediatric liver transplantation.
Fujita S; Fujikawa T; Mekeel K; Gonzalez R; Langham MR; Foley DP; Hemming AW; Howard RJ; Reed AI
Transplantation; 2006 Feb; 81(3):493-5. PubMed ID: 16477246
[No Abstract] [Full Text] [Related]
3. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
Rustgi VK
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
[TBL] [Abstract][Full Text] [Related]
5. Unusual case of Epstein-Barr virus DNA tissue positive: blood negative in a patient with post-transplant lymphoproliferative disorder.
Levenson BM; Ali SA; Timmons CF; Mittal N; Muthukumar A; Payne DA
Pediatr Transplant; 2009 Feb; 13(1):134-8. PubMed ID: 18482217
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD.
Mazariegos GV
Pediatr Transplant; 2004 Jun; 8(3):210-3. PubMed ID: 15176955
[No Abstract] [Full Text] [Related]
7. Lymphoproliferative disorder masquerading as rejection in liver transplant recipients--an early aggressive tumor with atypical presentation.
Howard TK; Klintmalm GB; Stone MJ; Cofer JB; Husberg BS; Goldstein RM; Gonwa TA
Transplantation; 1992 May; 53(5):1145-7. PubMed ID: 1316652
[No Abstract] [Full Text] [Related]
8. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
Elidemir O; Kancherla BS; Schecter MG; McKenzie ED; Morales DL; Heinle JS; Mallory GB
Pediatr Transplant; 2009 Aug; 13(5):606-10. PubMed ID: 19017289
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for posttransplant lymphoproliferative disorder.
Perkins JD
Liver Transpl; 2006 Jun; 12(6):1013-4. PubMed ID: 16823952
[No Abstract] [Full Text] [Related]
11. Cell mediated immunity (CMI) and post transplant viral infections--role of a functional immune assay to titrate immunosuppression.
Gautam A; Fischer SA; Yango AF; Gohh RY; Morrissey PE; Monaco AP
Int Immunopharmacol; 2006 Dec; 6(13-14):2023-6. PubMed ID: 17161357
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss.
Cherqui D; Duvoux C; Plassa F; Gaulard P; Julien M; Fagniez PL; Dhumeaux D; Goossens M; Farcet JP
Transplantation; 1993 Oct; 56(4):1023-6. PubMed ID: 8212183
[No Abstract] [Full Text] [Related]
13. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
[TBL] [Abstract][Full Text] [Related]
14. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.
Donckier V; Craciun L; Lucidi V; Buggenhout A; Troisi R; Rogiers X; Boon N; Gustot T; Moreno C; Bourgeois N; Colle I; Van Vlierberghe H; Nagy N; Praet M; Dernies T; Amrani M; Stordeur P; de Hemptinne B; Goldman M
Transplantation; 2009 May; 87(9 Suppl):S91-5. PubMed ID: 19424019
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
[TBL] [Abstract][Full Text] [Related]
16. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
19. Chronic active Epstein-Barr virus--is it real and how do you treat it?
Gross TG
Pediatr Transplant; 2009 Mar; 13(2):146-7. PubMed ID: 19067922
[No Abstract] [Full Text] [Related]
20. Is an ounce of prevention worth a pound of cure?
Gross TG
Pediatr Blood Cancer; 2006 Aug; 47(2):117-8. PubMed ID: 16276525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
